Richard Scolyer: I am super excited to now be receiving another dose of combi Immunotherapy (IO) for my glioblastoma.

Professor Richard Scolyer, CoMedical Director at Melanoma Institute Australia, Surgical Pathologist at Royal Prince Alfred Hospital, Conjoint Professor at University of Sydney, Editor of World Health Organization Skin (4th ed) and American Joint Committee on Cancer Melanoma Vice Chair (8th/9th Eds), shared the following on Twitter:

“I am super excited to now be receiving another dose of combi immunotherapy (IO) for my glioblastoma (GB). Fingers crossed incredible research data generated from my brain tumour after neoadjuvant combi IO will be translated into clinical benefit for me (& future GB patients)!”

Source: Richard Scolyer / Twitter